文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症患者血浆一氧化氮消耗升高并与不良结局相关

Plasma Nitric Oxide Consumption Is Elevated and Associated With Adverse Outcomes in Critically Ill Patients.
PubMed 文献 · Crit Care Med · 2023-08-21
一句话结论回顾性队列显示重症患者血浆NO消耗高于健康对照,且与脓毒症、ARDS、休克及院内死亡独立相关。

该回顾性队列研究在学术医疗中心成人ICU纳入362例重症患者与46例健康对照,用还原化学发光法测血浆NO消耗、比色法测游离血红蛋白。血浆NO消耗(均值[95%CI],µM)在重症患者高于健康对照(3.9[3.7-4.1] vs 2.1[1.8-2.5]),脓毒症高于非脓毒症(4.1[3.8-4.3] vs 3.6[3.3-3.8]),ARDS高于非ARDS(4.4[4.0-4.9] vs 3.7[3.6-3.9]),休克高于非休克(4.4[4.0-4.8] vs 3.6[3.4-3.8]),院内死亡者高于存活者(5.3[4.4-6.4] vs 3.7[3.6-3.9]),多因素分析中这些关系仍显著。血浆游离血红蛋白与NO消耗仅弱相关。作者认为过度血管内NO清除是脓毒症与重症不良结局的特征。

要点

  • 重症患者血浆NO消耗均值3.9 µM(95%CI 3.7-4.1),高于健康对照2.1 µM(95%CI 1.8-2.5)。
  • 院内死亡者血浆NO消耗5.3 µM(95%CI 4.4-6.4),高于存活者3.7 µM(95%CI 3.6-3.9),多因素分析后仍显著。
  • 脓毒症患者NO消耗4.1 µM(95%CI 3.8-4.3)高于非脓毒症3.6 µM(95%CI 3.3-3.8);休克患者4.4 µM(95%CI 4.0-4.8)高于非休克3.6 µM(95%CI 3.4-3.8)。
  • ARDS患者NO消耗4.4 µM(95%CI 4.0-4.9)高于非ARDS 3.7 µM(95%CI 3.6-3.9)。
  • 血浆游离血红蛋白与血浆NO消耗仅弱相关。

适用人群与场景

  • 学术医疗中心成人ICU的重症患者362例,另设健康对照46例。
  • 研究比较了脓毒症与非脓毒症、ARDS与非ARDS、休克与非休克、院内死亡者与存活者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入362例重症患者与46例健康对照,无干预。
  • 血浆NO消耗用还原化学发光法测定,游离血红蛋白用比色法测定。
  • 血浆NO消耗均值(95%CI,µM):重症患者3.9(3.7-4.1)vs 健康对照2.1(1.8-2.5);脓毒症4.1(3.8-4.3)vs 非脓毒症3.6(3.3-3.8);ARDS 4.4(4.0-4.9)vs 非ARDS 3.7(3.6-3.9);休克4.4(4.0-4.8)vs 非休克3.6(3.4-3.8);院内死亡者5.3(4.4-6.4)vs 存活者3.7(3.6-3.9)。
  • 上述关系在多因素分析中仍显著。
  • 血浆游离血红蛋白与血浆NO消耗仅弱相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 研究提示重症患者、尤其合并脓毒症、ARDS、休克或院内死亡者血浆NO消耗升高,但原文未据此给出检测或治疗推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Impaired nitric oxide (NO) bioavailability may contribute to microvascular dysfunction in sepsis. Excessive plasma NO consumption has been attributed to scavenging by circulating cell-free hemoglobin. This may be a mechanism for NO deficiency in sepsis and critical illness. We hypothesized that plasma NO consumption is high in critically ill patients, particularly those with sepsis, acute respiratory distress syndrome (ARDS), shock, and in hospital nonsurvivors. We further hypothesized that plasma NO consumption is correlated with plasma cell-free hemoglobin concentration.

DESIGN: Retrospective cohort study.

SETTING: Adult ICUs of an academic medical center.

PATIENTS AND SUBJECTS: Three hundred sixty-two critically ill patients and 46 healthy control subjects.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Plasma NO consumption was measured using reductive chemiluminescence and cell-free hemoglobin was measured with a colorimetric assay. Mean (95% CI) plasma NO consumption (µM) was higher in critically ill patients versus healthy control subjects (3.9 [3.7-4.1] vs 2.1 [1.8-2.5]), septic versus nonseptic patients (4.1 [3.8-4.3] vs 3.6 [3.3-3.8]), ARDS versus non-ARDS patients (4.4 [4.0-4.9] vs 3.7 [3.6-3.9]), shock vs nonshock patients (4.4 [4.0-4.8] vs 3.6 [3.4-3.8]), and hospital nonsurvivors versus survivors (5.3 [4.4-6.4] vs 3.7 [3.6-3.9]). These relationships remained significant in multivariable analyses. Plasma cell-free hemoglobin was weakly correlated with plasma NO consumption.

CONCLUSIONS: Plasma NO consumption is elevated in critically ill patients and independently associated with sepsis, ARDS, shock, and hospital death. These data suggest that excessive intravascular NO scavenging characterizes sepsis and adverse outcomes of critical illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Dony CA, Illipparambil LC, Maeda T, et al. Plasma Nitric Oxide Consumption Is Elevated and Associated With Adverse Outcomes in Critically Ill Patients. Crit Care Med. 2023. PMID: 37607081. doi:10.1097/CCM.0000000000006006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。